Calciphylaxis risk factors: Difference between revisions
Created page with "__NOTOC__ {{Calciphylaxis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflist|..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Calciphylaxis}} | {{Calciphylaxis}} | ||
{{CMG}} | |||
==Overview== | |||
==Risk Factors== | |||
Calciphylaxis most commonly occurs in patients with end-stage [[renal disease]] who are on [[hemodialysis]] or who have recently received a [[renal transplant]] ([[kidney transplant]]). Yet, calciphylaxis does not occur only in end-stage [[renal disease]] patients. It also has been reported in patients with [[breast cancer]] (treated with [[chemotherapy]]), liver [[cirrhosis]] (due to [[alcohol]] abuse), cholangiocarcinoma, [[Crohn's disease]], [[rheumatoid arthritis]] ([[RA]]), and [[systemic lupus erythematosus]] ([[SLE]]) (including [[SLE]] patients with or without [[chronic renal disease]]). | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 15:38, 28 September 2012
|
Calciphylaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Calciphylaxis risk factors On the Web |
|
American Roentgen Ray Society Images of Calciphylaxis risk factors |
|
Risk calculators and risk factors for Calciphylaxis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Factors
Calciphylaxis most commonly occurs in patients with end-stage renal disease who are on hemodialysis or who have recently received a renal transplant (kidney transplant). Yet, calciphylaxis does not occur only in end-stage renal disease patients. It also has been reported in patients with breast cancer (treated with chemotherapy), liver cirrhosis (due to alcohol abuse), cholangiocarcinoma, Crohn's disease, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) (including SLE patients with or without chronic renal disease).